Stay updated on ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial
Sign up to get notified when there's something new on the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page.

Latest updates to the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page
- Check7 days agoChange DetectedThe web page has been updated to version 2.16.5, and the previous version 2.16.4 has been removed. Additionally, a significant note regarding the modernization of ClinicalTrials.gov data ingest scheduled for July 2025 has been deleted.SummaryDifference2%
- Check14 days agoNo Change Detected
- Check21 days agoChange DetectedThe expected modernization date for the ClinicalTrials.gov data ingest has been updated from June 2025 to July 2025.SummaryDifference2%
- Check28 days agoNo Change Detected
- Check35 days agoChange DetectedThe web page has been updated from version v2.16.1 to v2.16.2.SummaryDifference0.1%
- Check43 days agoChange DetectedThe web page has been updated to indicate that the ClinicalTrials.gov data ingest will be modernized in June 2025, allowing API users to provide input before implementation. Additionally, the revision number has been updated from v2.15.2 to v2.16.1.SummaryDifference3%
- Check71 days agoChange DetectedThe web page has been updated from version 2.15.0 to version 2.15.2.SummaryDifference0.1%
- Check85 days agoChange DetectedThe page has undergone significant changes, including the removal of detailed study information regarding ALN-TTR02 and its safety evaluation in Japanese subjects, while introducing a new version reference and a specific mention of Transthyretin (TTR)-Mediated Amyloidosis.SummaryDifference16%
Stay in the know with updates to ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial
Enter your email address, and we'll notify you when there's something new on the ALN-TTR02 Safety in Japanese Healthy Volunteers Clinical Trial page.